StockNews.AI
AMTB
StockNews.AI
12 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB

1. Pomerantz LLP is probing securities fraud claims against Amerant Bancorp. 2. Amerant missed earnings estimates, reporting $0.28 EPS instead of $0.40. 3. The company's stock price dropped 13.09% to $16.93 post-earnings report. 4. Flat loan growth reported, impacted by increased payoffs and paydowns. 5. An investigation could lead to substantial legal and financial consequences.

3 mins saved
Full Article

FAQ

Why Very Bearish?

Missed earnings estimates by a significant margin and ongoing fraud investigation raise investor concerns. Historical trends show similar situations often lead to prolonged stock downturns.

How important is it?

Ongoing investigation and poor performance directly threaten investor trust and financial health. Historical context indicates high likelihood of price impact.

Why Short Term?

Immediate investor reactions due to earnings miss and fraud inquiry suggests short-term volatility. Past incidents show investor confidence can take time to rebuild.

Related Companies

BACJPMWFC
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Amerant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 23, 2025, Amerant issued a press release reporting its financial results for the first quarter of 2025.  Among other items, Amerant reported GAAP earnings per share of $0.28, missing consensus estimates by $0.12.  Commenting on the Company’s results, Amerant’s Chairman and Chief Executive Officer said that “loans were relatively flat quarter over quarter, as a result of increased payoffs and paydowns offsetting production in the first quarter.”  On this news, Amerant’s stock price fell $2.55 per share, or 13.09%, to close at $16.93 per share on April 24, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News